EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk

Durgesh Nandini Das, Akarsha Balnadupete iD, Rashmi Shetty iD, Venkadesa Perumal Gopu, Rushil Sajjan, Yashodhar P Bhandary, Amarnath S Marudamuthu iD, Christian Oliver, Aarav Patel, Aryan Patel, Buka Samten, Yoichiro Iwakura und 4 weitere

International Journal of Molecular Sciences · 14.02.2026 · 27 (4) · 1841

DOI: 10.3390/ijms27041841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2026. Verfasst von Durgesh Nandini Das und 15 weiteren Autor:innen. Beteiligte Einrichtung: Texas Lung Injury Institute, Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, 11937 US Highway 2…. Hauptthemen laut MEDLINE: Interleukin-17, Tumor Suppressor Protein p53, Lung Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health grants, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alveolar inflammation, elevated interleukin-17A (IL-17A), and fibrin deposition are common features in all forms of lung injury followed by fibrotic repair. Type II alveolar epithelial cell (AEC) viability, regulated by tumor suppressor protein p53 and changes in uPA-mediated fibrinolysis, has been linked to lung injury and pulmonary fibrosis (PF). Nevertheless, mechanistic details linking increased IL-17A with p53 and PAI-1 to lung injury and remodeling remain unclear. We found that IL-17A and its receptor (IL-17RA) are induced during various lung injuries. IL-17A augments IL-17RA, p53 and downstream PAI-1 with a concurrent decrease in uPA and its receptor (uPAR) in AECs. These changes promote AEC apoptosis, alveolar injury and PF. In addition, IL-17A causes a dose-dependent increase in IL-17RA and profibrogenic markers in lung fibroblasts (LFs), suggesting myofibroblast differentiation. We further found that inhibition of IL-17A by caveolin-1 scaffolding domain peptide (CSP) or its 7-mer deletion fragment (CSP7) inhibits AEC apoptosis, lung inflammation, and profibrogenic markers in LFs and PF. Further, treatment of mice with bleomycin-induced lung injury using CSP7, an anti-IL-17A antibody, or an IL-17RA blocking antibody attenuates total lung hydroxyproline and soluble collagen content, as well as levels of profibrogenic markers. These observations support the role of IL-17A/IL-17RA signaling in lung injury and post-injury remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17Tumor Suppressor Protein p53Lung InjuryAnimalsMiceReceptors, Interleukin-17Pulmonary FibrosisAlveolar Epithelial CellsBleomycinApoptosisSignal TransductionHumansFibroblastsPlasminogen Activator Inhibitor 1Mice, Inbred C57BLMale

Stichwörter der Autor:innen

CSP7IL-17Aalveolar epithelial cellsanti-IL-17A/IL-17RAlung fibrosis

Substanzen

Interleukin-17Tumor Suppressor Protein p53Receptors, Interleukin-17BleomycinPlasminogen Activator Inhibitor 1Il17ra protein, mouse

Autor:innen und Institutionen

  • Texas Lung Injury Institute, Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.
  • Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba 278-0022, Japan.
  • Radiation Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
  • Department of Medicine, Division of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, 4502 Medical Dr., San Antonio, TX 78229, USA.

ORCID-Profile: Akarsha Balnadupete, Rashmi Shetty, Amarnath S Marudamuthu, Jay Peters

Förderung

  • National Institute of Health grants
  • National Institute of Health

Zitieren

APA

Das, D. N., Balnadupete, A., Shetty, R., Gopu, V. P., Sajjan, R., Bhandary, Y. P., Marudamuthu, A. S., Oliver, C., Patel, A., Patel, A., Samten, B., Iwakura, Y., Tang, H., Citrin, D. E., Peters, J., & Shetty, S. (2026). Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk. International Journal of Molecular Sciences, 27(4), 1841. https://doi.org/10.3390/ijms27041841

Vancouver

Das DN, Balnadupete A, Shetty R, Gopu VP, Sajjan R, Bhandary YP, et al. Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk. International Journal of Molecular Sciences. 2026;27(4):1841. doi:10.3390/ijms27041841

BibTeX
@article{Das2026,
  author = {Das, Durgesh Nandini and Balnadupete, Akarsha and Shetty, Rashmi and Gopu, Venkadesa Perumal and Sajjan, Rushil and Bhandary, Yashodhar P and Marudamuthu, Amarnath S and Oliver, Christian and Patel, Aarav and Patel, Aryan and Samten, Buka and Iwakura, Yoichiro and Tang, Hua and Citrin, Deborah E and Peters, Jay and Shetty, Sreerama},
  title = {Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {4},
  pages = {1841},
  doi = {10.3390/ijms27041841}
}
Kostenlos starten →